Swedish Orphan Biovitrum AB

NEW
OTCPK:BIOVF (Sweden)  
$ 28.62 0 (0%) 11:08 PM EST
28.88
P/B:
2.99
Enterprise V:
$ 11.42B
Volume:
-
Avg Vol (2M):
310.00
Trade In:
Volume:
-
Avg Vol (2M):
310.00

Business Description

Description
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement programs in 2006. Biovitrum acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched hemophilia products Alprolix and Eloctate in Europe in 2016, and Altuvoct in 2024. Sobi has been building its immunology pipeline (rare disease drug Gamifant, US rights to RSV antibodies Synagis and Beyfortus, gout drug SEL-212, complement drug Aspaveli) and a broader hematology pipeline (thrombocytopenia drug Doptelet, blood cancer drug Zynlonta, myelofibrosis drug Vonjo).

Financials (Next Earnings Date:2025-02-05)

BIOVF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BIOVF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Swedish Orphan Biovitrum AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,460.895
EPS (TTM) ($) 0.991
Beta 0.52
3-Year Sharpe Ratio 0.17
3-Year Sortino Ratio 0.23
Volatility % 43.17
14-Day RSI 45.57
14-Day ATR ($) 0.192305
20-Day SMA ($) 28.19606
12-1 Month Momentum % 35.55
52-Week Range ($) 22.87 - 32.25
Shares Outstanding (Mil) 343.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Swedish Orphan Biovitrum AB Filings

Filing Date Document Date Form
No Filing Data

Swedish Orphan Biovitrum AB Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Swedish Orphan Biovitrum AB Frequently Asked Questions

What is Swedish Orphan Biovitrum AB(BIOVF)'s stock price today?
The current price of BIOVF is $28.62. The 52 week high of BIOVF is $32.25 and 52 week low is $22.87.
When is next earnings date of Swedish Orphan Biovitrum AB(BIOVF)?
The next earnings date of Swedish Orphan Biovitrum AB(BIOVF) is 2025-02-05.
Does Swedish Orphan Biovitrum AB(BIOVF) pay dividends? If so, how much?
Swedish Orphan Biovitrum AB(BIOVF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1